Skip to main content
. 2024 Feb 16;17(2):e13687. doi: 10.1111/cts.13687

FIGURE 1.

FIGURE 1

Study design. aOn Day 14, clesacostat 15 mg was co‐administered with ervogastat 300 mg in the morning only; no afternoon dose was administered. bOn Day 14, ervogastat 300 mg was co‐administered with clesacostat 15 mg in the morning only; no afternoon dose was administered. BID, twice daily; CRU, Clinical Research Unit.